Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085684927> ?p ?o ?g. }
- W2085684927 endingPage "1324" @default.
- W2085684927 startingPage "1318" @default.
- W2085684927 abstract "Treatment of chronic hepatitis C with Interferon (IFN) alpha2b monotherapy results in 10% to 15% sustained virological response (SVR). Combining IFN with ribavirin increases this response. In this analysis, using the Markov model, 6 treatment strategies for chronic hepatitis C (previously untreated) were compared on the basis of incremental cost per additional quality-adjusted life years ($/QALY). Our results showed that the no treatment strategy was associated with a cost of $38,747 and 13.10 QALYs. The strategy using IFN alone for 48 weeks was associated with a cost of $35,642 and 14.05 QALYs. The strategy using IFN monotherapy followed by combination therapy for nonresponders and relapsers was associated with a cost of $34, 561 and 15.53 QALYs. A similar strategy, but limiting combination to relapsers only, was associated with a cost of $34,758 and 14.40 QALYs. The strategy using IFN with ribavirin as the initial therapy for all patients was associated with a cost of $34,792 and 15.31 QALYs. Finally, the strategy using viral genotyping first and then adjusting the duration of combination therapy based on genotype was associated with a cost of $37,263 and 15.89 QALYs. The strategy using genotyping to guide duration of combination therapy was the most cost-effective approach with an incremental cost-effectiveness ratio of $7,500 per QALY. Sensitivity analyses confirmed the robustness of these results. We conclude that combination of IFN and ribavirin with duration of therapy based on the viral genotype, is a cost-effective approach in treating patients with chronic hepatitis C." @default.
- W2085684927 created "2016-06-24" @default.
- W2085684927 creator A5001332221 @default.
- W2085684927 creator A5047784168 @default.
- W2085684927 creator A5064179616 @default.
- W2085684927 creator A5080386622 @default.
- W2085684927 date "1999-11-01" @default.
- W2085684927 modified "2023-10-12" @default.
- W2085684927 title "Cost effectiveness of interferon ?2b combined with ribavirin for the treatment of chronic hepatitis C" @default.
- W2085684927 cites W1968050550 @default.
- W2085684927 cites W1999585106 @default.
- W2085684927 cites W2001137775 @default.
- W2085684927 cites W2002345728 @default.
- W2085684927 cites W2005863439 @default.
- W2085684927 cites W2018370670 @default.
- W2085684927 cites W2019881389 @default.
- W2085684927 cites W2027151038 @default.
- W2085684927 cites W2028145691 @default.
- W2085684927 cites W2041602034 @default.
- W2085684927 cites W2055002900 @default.
- W2085684927 cites W2058200448 @default.
- W2085684927 cites W2058361955 @default.
- W2085684927 cites W2063089198 @default.
- W2085684927 cites W2072939892 @default.
- W2085684927 cites W2075957674 @default.
- W2085684927 cites W2079002457 @default.
- W2085684927 cites W208665126 @default.
- W2085684927 cites W2090802921 @default.
- W2085684927 cites W2114327359 @default.
- W2085684927 cites W2121879722 @default.
- W2085684927 cites W2133580842 @default.
- W2085684927 cites W2142285314 @default.
- W2085684927 cites W2313891666 @default.
- W2085684927 cites W2317554121 @default.
- W2085684927 cites W2334978547 @default.
- W2085684927 cites W2336799715 @default.
- W2085684927 cites W2341829866 @default.
- W2085684927 cites W4300498803 @default.
- W2085684927 doi "https://doi.org/10.1002/hep.510300518" @default.
- W2085684927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10534357" @default.
- W2085684927 hasPublicationYear "1999" @default.
- W2085684927 type Work @default.
- W2085684927 sameAs 2085684927 @default.
- W2085684927 citedByCount "152" @default.
- W2085684927 countsByYear W20856849272012 @default.
- W2085684927 countsByYear W20856849272013 @default.
- W2085684927 countsByYear W20856849272014 @default.
- W2085684927 countsByYear W20856849272015 @default.
- W2085684927 countsByYear W20856849272016 @default.
- W2085684927 countsByYear W20856849272017 @default.
- W2085684927 countsByYear W20856849272019 @default.
- W2085684927 countsByYear W20856849272020 @default.
- W2085684927 crossrefType "journal-article" @default.
- W2085684927 hasAuthorship W2085684927A5001332221 @default.
- W2085684927 hasAuthorship W2085684927A5047784168 @default.
- W2085684927 hasAuthorship W2085684927A5064179616 @default.
- W2085684927 hasAuthorship W2085684927A5080386622 @default.
- W2085684927 hasBestOaLocation W20856849271 @default.
- W2085684927 hasConcept C104317684 @default.
- W2085684927 hasConcept C112930515 @default.
- W2085684927 hasConcept C126322002 @default.
- W2085684927 hasConcept C135763542 @default.
- W2085684927 hasConcept C142462285 @default.
- W2085684927 hasConcept C203014093 @default.
- W2085684927 hasConcept C2522874641 @default.
- W2085684927 hasConcept C2776178377 @default.
- W2085684927 hasConcept C2776455275 @default.
- W2085684927 hasConcept C2776999253 @default.
- W2085684927 hasConcept C2780040827 @default.
- W2085684927 hasConcept C2909179924 @default.
- W2085684927 hasConcept C3019080777 @default.
- W2085684927 hasConcept C3020491458 @default.
- W2085684927 hasConcept C31467283 @default.
- W2085684927 hasConcept C55493867 @default.
- W2085684927 hasConcept C64332521 @default.
- W2085684927 hasConcept C71924100 @default.
- W2085684927 hasConcept C86803240 @default.
- W2085684927 hasConceptScore W2085684927C104317684 @default.
- W2085684927 hasConceptScore W2085684927C112930515 @default.
- W2085684927 hasConceptScore W2085684927C126322002 @default.
- W2085684927 hasConceptScore W2085684927C135763542 @default.
- W2085684927 hasConceptScore W2085684927C142462285 @default.
- W2085684927 hasConceptScore W2085684927C203014093 @default.
- W2085684927 hasConceptScore W2085684927C2522874641 @default.
- W2085684927 hasConceptScore W2085684927C2776178377 @default.
- W2085684927 hasConceptScore W2085684927C2776455275 @default.
- W2085684927 hasConceptScore W2085684927C2776999253 @default.
- W2085684927 hasConceptScore W2085684927C2780040827 @default.
- W2085684927 hasConceptScore W2085684927C2909179924 @default.
- W2085684927 hasConceptScore W2085684927C3019080777 @default.
- W2085684927 hasConceptScore W2085684927C3020491458 @default.
- W2085684927 hasConceptScore W2085684927C31467283 @default.
- W2085684927 hasConceptScore W2085684927C55493867 @default.
- W2085684927 hasConceptScore W2085684927C64332521 @default.
- W2085684927 hasConceptScore W2085684927C71924100 @default.
- W2085684927 hasConceptScore W2085684927C86803240 @default.
- W2085684927 hasIssue "5" @default.
- W2085684927 hasLocation W20856849271 @default.